Newbridge Financial Services Group, Inc. - PSYCHEMEDICS CORP ownership

PSYCHEMEDICS CORP's ticker is PMD and the CUSIP is 744375205. A total of 26 filers reported holding PSYCHEMEDICS CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Newbridge Financial Services Group, Inc. ownership history of PSYCHEMEDICS CORP
ValueSharesWeighting
Q4 2022$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q3 2022$1,0000.0%1500.0%0.00%0.0%
Q2 2022$1,0000.0%1500.0%0.00%
Q1 2022$1,0000.0%1500.0%0.00%
Q4 2021$1,0000.0%1500.0%0.00%
-100.0%
Q3 2021$1,0000.0%1500.0%0.00%0.0%
Q2 2021$1,0000.0%1500.0%0.00%0.0%
Q1 2021$1,0000.0%1500.0%0.00%0.0%
Q4 2020$1,000
-93.8%
150
-95.9%
0.00%
-93.8%
Q3 2020$16,0003,6500.02%
Other shareholders
PSYCHEMEDICS CORP shareholders Q4 2021
NameSharesValueWeighting ↓
WEALTH EFFECTS LLC 40,001$276,0000.13%
SANTA MONICA PARTNERS LP 20,000$138,0000.10%
Invenomic Capital Management LP 135,631$769,0000.08%
Cannell Capital 78,306$540,0000.08%
RBF Capital, LLC 144,231$996,0000.06%
CRAWFORD INVESTMENT COUNSEL INC 266,502$1,839,0000.04%
Ancora Advisors LLC 80,728$557,0000.01%
HighMark Wealth Management LLC 2,039$14,0000.01%
Renaissance Technologies 341,422$2,356,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 34,618$240,0000.00%
View complete list of PSYCHEMEDICS CORP shareholders